The CARE Training program employs a "flipped classroom" model, drawing on past CARE panels to create training modules for graduate and professional students, postdocs, and junior faculty seeking to satisfy federal guidelines for ethics training.
Session Overview:
The CARE panel, "Conflicts of Interest in Research: Is Disclosure Enough?" featured Matthew McCoy (Medical Ethics and Health Policy, UPenn) and Dr. Clark Anderson, MD (Professor Emeritus, Division of Rheumatology and Immunology).
A New York Times/Pro Publica investigation recently exposed dozens of leading medical figures who have failed to report their financial relationships with pharmaceutical and health care companies when their studies are published in medical journals. This has resulted in high profile resignations from leading medical research centers and investigations into the policies of leading journals. In this module, you will reflect on the nature of this pressing problem and how it can best be addressed.
Learning Objectives:
- At the end of this session, you will be able to identify the factors that contribute to conflicts of interest in research.
- At the end of this session, you will understand the ways in which conflicts of interest undermine research integrity and public trust in science.
- At the end of this session, you will be able to strategize ways in which to mitigate potential conflicts of interest in your lab and research institutions.
Readings Prior to Session:
- CEHV Blog Post by Matt McCoy:
- Botkin JR. Should Failure to Disclose Significant Financial Conflicts of Interest Be Considered Research Misconduct? JAMA. 2018;320(22):2307-2308.
- Brody H. Clarifying Conflict of Interest. Am J Bioeth. 2011;11(1):23-28. doi:10.1080/15265161.2010.534530
- Angell M. Opinion | Transparency Hasn’t Stopped Drug Companies From Corrupting Medical Research. The New York Times.
Video Prior to Session: